Finnrick - Ensuring a Safer and More Transparent Supply Chain

Free peptides test: now with paid endotoxins contamination option

Heman Peptide HM

Heman Peptide HM

Tirzepatide

Finnrick tested 5 samples of Tirzepatide (GLP-1 and GIP agonist) from Heman Peptide HM between 7 Oct 2025 and 18 Feb 2026. Test scores average over 4, no score below 3, and at least 2 tests warrant a tentative Finnrick Rating of D (Poor).

Finnrick Rating™
Tentative Rating
Heman Peptide HM
Tirzepatide
Tested 5 Samples
Last test 18 Feb 2026

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

All Tirzepatide tests from Heman Peptide HM

Samples are tested in commercial labs

Tests Count

5

Scores

AVG6.6MIN3.3MAX9.7

Last

18 Feb 2026

First

7 Oct 2025
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
18 Feb 2026View9.710mg10.6mg+6.0%99.90%TR10No Label / Silver Crimp / White CapLab EPublic
18 Dec 2025View7.550mg48.6mg-2.8%99.70%(no batch ID)No Label / Silver Crimp / Red CapLab GPublic
23 Nov 2025View8.360mg66.5mg+10.8%99.90%2025-11White Label / Silver Crimp / Blue CapLab GPublic
24 Oct 2025View4.230mg43.27mg+44.2%99.70%(no batch ID)No Label / Silver Crimp / Red CapLab GPublic
7 Oct 2025View3.35mg5.8mg+16.0%98.80%(no batch ID)No Label / Silver Crimp / White Cap Lab GPublic